The vast majority of children with idiopathic nephrotic syndrome respond well to corticosteroid treatment. However, as many as 80% experience  a relapse. Repeated and prolonged courses of steroids in these children often result in long-term complications. The goal of treatment is to reduce the rate of relapses, the cumulative dose of corticosteroids, and the incidence of serious complications. In order to minimize the side effects of steroid therapy, different steroid doses and schedules are used. Standard therapy of 1 month alternate day steroid for managing relapse results in further relapse  among 50% of children. Various recent reports are suggesting that prolongation of this alternate day steroid keeping the cumulative steroid load same, may produce better efficacy in preventing further relapses.^1-5 Studies comparing the usefulness of these two schedules are lacking. In our proposed randomized controlled trial, we want to compare the efficacy and safety of one month vs. two month of alternate day oral steroid in managing relapse of Idiopathic Steroid Sensitive Nephrotic Syndrome.